Nomenclature
CAS number: 69049-73-6
9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4
H-pyrano[3,2-
g]quinoline-2,8-dicarboxylic acid; 4,6-dioxo-1-ethyl-10-propyl-4
H,6
H-pyrano[3,2-
g]quinoline-2,8-dicarboxylic acid; FPL-59002.
C
19H
17NO
7; mol wt 371.34.
C 61.45%, H 4.61%, N 3.77%, O 30.16%.
Description and references
Mast cell stabilizer; also modulates production
of cytokines by stimulated epithelial cells. Prepn and pharmacology:
H. Cairns, D. Cox, BE 866622; eidem, US 4474787 (1978, 1984 both to Fisons); H. Cairns et al., J.
Med. Chem. 28, 1832 (1985). Series of articles
on pharmacology, pharmacokinetics and clinical profile in allergic
rhinitis: Allergy 51, Suppl. 28, 8-34 (1996). Comparative clinical trial with cromolyn sodium, q.v., in asthma:
H. J. Schwartz et al., Chest 109, 945 (1996).
Properties
Yellow powder, mp 298-300° (dec).Derivative
Disodium salt.
Nomenclature
CAS number: 69049-74-7
FPL-59002KP; Halamid (Viatris); Irtan (Aventis); Rapitil (Aventis); Tilade (Aventis); Tilarin (Aventis); Tilavist (Aventis).
C
19H
15NNa
2O
7; mol wt 415.30.
C 54.95%, H 3.64%, N 3.37%, Na 11.07%, O 26.97%.
Properties
Pale yellow powder. Sol in water.Therapeutic Category
Antiallergic; antiasthmatic.
Keywords
Antiallergic; Antiasthmatic (Nonbronchodilator)